|
US2018235918A1
|
|
Long-chain amphipathic dicarboxylic acids for treatment of diabetes type-1
|
|
US2020375933A1
|
|
Diabetes treatment regimens using alpha, alpha-substituted long-chain amphipathic carboxylates
|
|
EP2787986A1
|
|
Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof
|
|
CN101677982A
|
|
Combination therapy, composition and methods for the treatment of cardiovascular disorders
|
|
EP1699448A2
|
|
Methods of administering 3,3,14,14 tetramethyl hexadecane 1,16 dioic acid
|
|
AU3436302A
|
|
Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
